Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2022-03-07 to 2026-10-16
ROUNDS
2
led 1, joined 1
LED ROUNDS · USD
$33.0M
across 1 round · 1 co-led, split evenly
CO-INVESTORS
6
named beside it
Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2022-03-07 to 2026-10-16
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Microbiotica A clinical-stage biopharma company developing a pipeline of orally-dosed, precision microbiome medicines | Series C Verified against 1 of 8 sources | $47.7M | 2026-10-16 | [ PART ] |
Microbiotica A clinical-stage biopharma company developing a pipeline of orally-dosed, precision microbiome medicines | Series B Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $65.9M | 2022-03-07 | [ LEAD ] |